OPKO Health Free Cash Flow 2010-2024 | OPK
OPKO Health Annual Free Cash Flow | |
---|---|
2023 | -41.76 |
2022 | -117.82 |
2021 | 72.21 |
2020 | 6.04 |
2019 | -184.59 |
2018 | -135.78 |
2017 | -131.33 |
2016 | 14.90 |
2015 | 153.18 |
2014 | -95.11 |
2013 | -58.98 |
2012 | -26.89 |
2011 | -20.45 |
2010 | -19.49 |
2009 | -23.58 |
OPKO Health Quarterly Free Cash Flow | |
---|---|
2024-09-30 | -158.51 |
2024-06-30 | -73.56 |
2024-03-31 | -39.96 |
2023-12-31 | -41.76 |
2023-09-30 | -2.05 |
2023-06-30 | -31.22 |
2023-03-31 | -25.36 |
2022-12-31 | -117.82 |
2022-09-30 | -80.31 |
2022-06-30 | -41.09 |
2022-03-31 | -24.76 |
2021-12-31 | 72.21 |
2021-09-30 | 84.53 |
2021-06-30 | -7.44 |
2021-03-31 | 16.85 |
2020-12-31 | 6.04 |
2020-09-30 | -21.48 |
2020-06-30 | -74.88 |
2020-03-31 | -48.99 |
2019-12-31 | -184.59 |
2019-09-30 | -134.80 |
2019-06-30 | -108.74 |
2019-03-31 | -51.92 |
2018-12-31 | -135.78 |
2018-09-30 | -98.24 |
2018-06-30 | -63.27 |
2018-03-31 | -40.95 |
2017-12-31 | -131.33 |
2017-09-30 | -122.27 |
2017-06-30 | -69.99 |
2017-03-31 | -40.36 |
2016-12-31 | 14.90 |
2016-09-30 | -14.19 |
2016-06-30 | 21.48 |
2016-03-31 | -19.02 |
2015-12-31 | 153.18 |
2015-09-30 | 168.95 |
2015-06-30 | 203.30 |
2015-03-31 | 238.43 |
2014-12-31 | -95.11 |
2014-09-30 | -68.22 |
2014-06-30 | -45.68 |
2014-03-31 | -23.47 |
2013-12-31 | -58.98 |
2013-09-30 | -31.96 |
2013-06-30 | -8.61 |
2013-03-31 | -15.50 |
2012-12-31 | -26.89 |
2012-09-30 | -20.75 |
2012-06-30 | -18.17 |
2012-03-31 | -11.67 |
2011-12-31 | -20.45 |
2011-09-30 | -13.16 |
2011-06-30 | -9.11 |
2011-03-31 | -4.79 |
2010-12-31 | -19.49 |
2010-09-30 | -17.86 |
2010-06-30 | -11.80 |
2010-03-31 | -2.88 |
2009-12-31 | -23.58 |
2009-09-30 | -20.12 |
2009-06-30 | -15.04 |
2009-03-31 | -8.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $1.119B | $0.864B |
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Intuitive Surgical (ISRG) | United States | $212.123B | 97.31 |
Thermo Fisher Scientific (TMO) | United States | $203.433B | 24.33 |
Edwards Lifesciences (EW) | United States | $44.937B | 29.08 |
Alcon (ALC) | Switzerland | $44.417B | 29.72 |
IDEXX Laboratories (IDXX) | United States | $36.400B | 41.66 |
DexCom (DXCM) | United States | $34.790B | 53.98 |
IQVIA Holdings (IQV) | United States | $34.065B | 18.87 |
Mettler-Toledo (MTD) | United States | $26.604B | 30.90 |
Waters (WAT) | United States | $21.953B | 31.15 |
STERIS (STE) | Ireland | $21.550B | 24.65 |
SONOVA HOLDING (SONVY) | Switzerland | $20.044B | 0.00 |
Hologic (HOLX) | United States | $14.190B | 15.31 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $13.755B | 14.12 |
Globus Medical (GMED) | United States | $11.429B | 28.94 |
Sysmex ADR (SSMXY) | Japan | $11.267B | 35.33 |
Penumbra (PEN) | United States | $10.311B | 101.00 |
Masimo (MASI) | United States | $9.707B | 46.97 |
Glaukos (GKOS) | United States | $8.447B | 0.00 |
Teleflex (TFX) | United States | $7.776B | 12.40 |
Integer Holdings (ITGR) | United States | $4.729B | 26.81 |
Inari Medical (NARI) | United States | $4.679B | 0.00 |
PROCEPT BioRobotics (PRCT) | United States | $3.528B | 0.00 |
Veracyte (VCYT) | United States | $3.186B | 95.61 |
Nihon Kohden (NHNKY) | Japan | $2.705B | 14.78 |
LivaNova (LIVN) | United Kingdom | $2.589B | 14.95 |
TransMedics (TMDX) | United States | $2.422B | 76.79 |
Elekta AB (EKTAY) | Sweden | $2.392B | 21.50 |
Tandem Diabetes Care (TNDM) | United States | $2.198B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.866B | 9.75 |
Alphatec Holdings (ATEC) | United States | $1.523B | 0.00 |
Pulse Biosciences (PLSE) | United States | $1.291B | 0.00 |
Artivion (AORT) | United States | $1.260B | 83.50 |
RxSight (RXST) | United States | $1.201B | 0.00 |
Paragon 28 (FNA) | United States | $1.093B | 0.00 |
Beta Bionics (BBNX) | United States | $0.935B | 0.00 |
AxoGen (AXGN) | United States | $0.798B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.792B | 17.31 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.762B | 12.94 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.711B | 0.00 |
IRadimed (IRMD) | United States | $0.700B | 36.82 |
SiBone (SIBN) | United States | $0.687B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.628B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.596B | 0.00 |
Delcath Systems (DCTH) | United States | $0.521B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.507B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.505B | 0.00 |
Semler Scientific (SMLR) | United States | $0.460B | 24.23 |
AngioDynamics (ANGO) | United States | $0.418B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.416B | 22.51 |
NeuroPace (NPCE) | United States | $0.367B | 0.00 |
CVRx (CVRX) | United States | $0.366B | 0.00 |
Anteris Technologies Global (AVR) | Australia | $0.287B | 0.00 |
Inogen (INGN) | United States | $0.253B | 0.00 |
Accuray (ARAY) | United States | $0.229B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.220B | 0.00 |
Nevro (NVRO) | United States | $0.214B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.200B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.150B | 0.00 |
Sight Sciences (SGHT) | United States | $0.139B | 0.00 |
Neuronetics (STIM) | United States | $0.132B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.127B | 0.00 |
LENSAR (LNSR) | United States | $0.122B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.106B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
908 Devices (MASS) | United States | $0.097B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.090B | 13.77 |
Vicarious Surgical (RBOT) | United States | $0.089B | 0.00 |
Hyperfine (HYPR) | United States | $0.088B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.087B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.085B | 0.00 |
InspireMD (NSPR) | Israel | $0.077B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
Positron (POSC) | United States | $0.060B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.058B | 30.14 |
Microbot Medical (MBOT) | United States | $0.057B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
Spectral AI (MDAI) | United States | $0.039B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.033B | 0.00 |
Precision Optics (POCI) | United States | $0.031B | 0.00 |
Envoy Medical (COCH) | United States | $0.031B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
NexGel (NXGL) | United States | $0.024B | 0.00 |
DarioHealth (DRIO) | United States | $0.024B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
PAVmed (PAVM) | United States | $0.009B | 0.00 |
Nuwellis (NUWE) | United States | $0.006B | 0.00 |
Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
Tenon Medical (TNON) | United States | $0.005B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Venus Concept (VERO) | Canada | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Avinger (AVGR) | United States | $0.002B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |